Home › Funds › Bain Capital Life Sciences Investors, LLC › IRON

Bain Capital Life Sciences Investors, LLC position in IRON

DISC MEDICINE INC · Health Care

Bain Capital Life Sciences Investors, LLC reported holding 141,234 shares of IRON (DISC MEDICINE INC) in its Q3 2026 13F filing — a position valued at US$9.2M, representing 0.64% of its reported portfolio and ranking #18 among its reported holdings. Bain Capital Life Sciences Investors, LLC has disclosed IRON holdings in 11 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)141.23K sh
Reported value held$9.25M
Portfolio Weight0.64%
First reportedQ3 2023
Last changeHold
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Bain Capital Life Sciences Investors, LLC's IRON position evolved

Bain Capital Life Sciences Investors, LLC first disclosed a stake in IRON in Q3 2023 at 1,332,545 shares (US$62.6M). The position peaked in Q3 2024 at 1,795,735 shares, worth US$88.2M. Across 11 filings, Bain Capital Life Sciences Investors, LLC increased the stake 1 time(s), trimmed it 3 time(s) and left it unchanged 5 time(s). The most recent filing (Q3 2026) shows 141,234 shares valued at US$9.2M. Notable position changes include a 36% increase in Q2 2024 (shares rose 9% over the following quarter), a 45% trim in Q4 2024 (shares fell 22% over the following quarter), a 41% trim in Q2 2025 (shares rose 25% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.33M $62.60M New
Q4 2023 1.33M $76.97M Hold
Q1 2024 1.32M $82.01M Reduce
Q2 2024 1.80M $80.93M Add
Q3 2024 1.80M $88.24M Hold
Q4 2024 983.50K $62.35M Reduce
Q1 2025 983.50K $48.82M Hold
Q2 2025 583.50K $30.90M Reduce
Q1 2026 141.23K $9.03M New
Q2 2026 141.23K $10.33M Hold
Q3 2026 141.23K $9.25M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About IRON and 13F data

IRON (DISC MEDICINE INC) is a Health Care company. 36 other funds we track also report a position in IRON — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$179.2M), Vestal Point Capital, LP (US$113.4M), Frazier Life Sciences Management, L.P. (US$99.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IRON

All IRON fund holders →

FAQ

How long has Bain Capital Life Sciences Investors, LLC held IRON?

Bain Capital Life Sciences Investors, LLC has disclosed IRON holdings in 11 of the last 13 reported quarters, going back to Q3 2023.

What is Bain Capital Life Sciences Investors, LLC's current position in IRON?

As of Q3 2026, Bain Capital Life Sciences Investors, LLC holds 141.23K shares of IRON (DISC MEDICINE INC), valued at $9.25M, representing 0.64% of its reported portfolio and ranking #18.

Has Bain Capital Life Sciences Investors, LLC been buying or selling IRON?

In the latest 13F filing (Q3 2026), Bain Capital Life Sciences Investors, LLC held unchanged its position in IRON. The position peaked in Q3 2024 at 1.80M shares.

Which other funds hold IRON?

Other major institutional holders of IRON include RA CAPITAL MANAGEMENT, L.P., Vestal Point Capital, LP, Frazier Life Sciences Management, L.P., among 36 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.